Jeff Marrazzo, the first and only CEO at Spark Therapeutics, is stepping down

Marrazzo’s departure from the CHOP spinout company he co-founded in 2013 comes a little more than two years after it was sold to Swiss health care giant Roche for $4.3 billion.

Leave a Reply